• 1. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 2. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 3. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 4. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 5. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig

Professional Introduction to 9-Acridinecarboxaldehyde,2-methyl- (CAS No. 70401-29-5)

9-Acridinecarboxaldehyde,2-methyl-, with the CAS number 70401-29-5, is a significant compound in the field of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic aldehyde derivative belongs to the acridine family, a class of nitrogen-containing aromatic compounds known for their diverse biological activities. The structural features of 9-Acridinecarboxaldehyde,2-methyl- make it a valuable intermediate in the synthesis of various pharmacologically active molecules, particularly those targeting neurological and oncological applications.

The compound’s molecular structure consists of a central acridine core substituted with a formyl group at the 9-position and a methyl group at the 2-position. This specific arrangement imparts unique electronic and steric properties, making it an attractive scaffold for medicinal chemists. The formyl group (–CHO) serves as a reactive handle for further functionalization, enabling the construction of more complex molecules through condensation reactions, such as Schiff base formation or Michael additions.

In recent years, 9-Acridinecarboxaldehyde,2-methyl- has garnered attention in the development of novel therapeutic agents. One particularly promising area is its application in the synthesis of small-molecule inhibitors targeting protein-protein interactions (PPIs) involved in cancer progression. Acridine derivatives are well-documented for their ability to disrupt critical cellular pathways by binding to specific protein targets. The aldehyde functionality in 9-Acridinecarboxaldehyde,2-methyl- allows for facile derivatization into bisubstrate inhibitors, which can simultaneously engage two different binding sites on a protein target, enhancing binding affinity and selectivity.

Recent studies have highlighted the potential of 9-Acridinecarboxaldehyde,2-methyl- as a precursor in the design of kinase inhibitors. Kinases are enzymes that play pivotal roles in cell signaling cascades, and their dysregulation is often associated with diseases such as cancer. By modifying the acridine core with appropriate substituents derived from 9-Acridinecarboxaldehyde,2-methyl-, researchers have been able to develop potent inhibitors that selectively inhibit aberrant kinase activity without affecting normal cellular processes. This approach has led to several preclinical candidates that show promise in oncology applications.

The utility of 9-Acridinecarboxaldehyde,2-methyl- extends beyond oncology into neurology. Emerging evidence suggests that acridine derivatives may modulate neurotransmitter receptors and ion channels, making them candidates for treating neurological disorders such as Alzheimer’s disease and Parkinson’s disease. The aldehyde group provides a versatile platform for synthesizing acridine-based ligands that can interact with specific neural receptors or modulate neuronal excitability. For instance, derivatives of 9-Acridinecarboxaldehyde,2-methyl- have been investigated for their potential to inhibit amyloid-beta aggregation, a hallmark pathological feature of Alzheimer’s disease.

The synthetic versatility of 9-Acridinecarboxaldehyde,2-methyl- also makes it valuable in materials science and agrochemical applications. Its ability to participate in diverse chemical reactions allows for the creation of functionalized polymers and coatings with enhanced properties. Additionally, some acridine derivatives exhibit antimicrobial activity, making them useful in developing novel pesticides or preservatives. While these applications are still under exploration, they underscore the broad utility of this compound beyond traditional pharmaceuticals.

From a computational chemistry perspective, the electronic properties of 9-Acridinecarboxaldehyde,2-methyl- have been extensively studied using density functional theory (DFT) and other quantum mechanical methods. These studies have provided insights into how structural modifications influence reactivity and binding affinity. For example, computational modeling has shown that introducing electron-withdrawing groups near the formyl group enhances its electrophilicity, facilitating faster reaction rates in subsequent synthetic steps. Such insights are crucial for designing next-generation acridine-based drugs with improved pharmacokinetic profiles.

The industrial production of 9-Acridinecarboxaldehyde,2-methyl- typically involves multi-step organic synthesis starting from readily available precursors such as 2-methylaniline or 2-methylphenol. Advances in catalytic methods have enabled more efficient and sustainable synthetic routes, reducing waste generation and energy consumption. Green chemistry principles are increasingly being applied to optimize these processes, ensuring compliance with environmental regulations while maintaining high yields and purity standards.

In conclusion,9-Acridinecarboxaldehyde, CAS No. 70401-29-5, is a multifaceted compound with significant potential across multiple domains of chemical research and application. Its unique structural features and reactivity make it an indispensable tool for medicinal chemists seeking to develop innovative therapeutics targeting diseases such as cancer and neurodegenerative disorders. As research continues to uncover new biological functions and synthetic methodologies for this class of compounds,9-Acridinecarboxaldehyde, CAS No. 70401-29-5, will undoubtedly remain at the forefront of academic and industrial investigations.

• 1196-70-9(1H-Indole-6-carbaldehyde)
• 4113-04-6(Quinoline-6-carbaldehyde)
• 99585-18-9(9H-Carbazole-2-carboxaldehyde)
• 787615-01-4(Isoquinoline-8-carbaldehyde)
• 885-23-4(acridine-9-carbaldehyde)
• 49573-30-0(7-Quinolinecarbaldehyde)
• 22934-41-4(Quinoline-5-carbaldehyde)
• 1074-86-8(Indole-4-carboxaldehyde)
• 4363-93-3(Quinoline-4-carbaldehyde)
• 91804-75-0(1,10-Phenanthroline-5-carbaldehyde)